Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
55 | 3 | CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY//CHROMATIN | 94586 |
2124 | 2 | HISTONE DEACETYLASE INHIBITOR//HISTONE DEACETYLASE//HDAC INHIBITOR | 5445 |
25724 | 1 | PHENYLACETATE//PHENYLBUTYRATE//BLEOMYCIN AMPLIFICATION | 295 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PHENYLACETATE | authKW | 869453 | 8% | 35% | 23 |
2 | PHENYLBUTYRATE | authKW | 615548 | 7% | 26% | 22 |
3 | BLEOMYCIN AMPLIFICATION | authKW | 549442 | 2% | 86% | 6 |
4 | ANTINEOPLASTON AS2 1 | authKW | 534181 | 2% | 100% | 5 |
5 | FENTONS PATHWAY | authKW | 320509 | 1% | 100% | 3 |
6 | SODIUM PHENYLACETATE NAPA | authKW | 320509 | 1% | 100% | 3 |
7 | ANTINEOPLASTON A10 | authKW | 284894 | 1% | 67% | 4 |
8 | ANTINEOPLASTON | authKW | 213672 | 1% | 100% | 2 |
9 | EQUIPE ONCOL CELLULAIRE MOL | address | 213672 | 1% | 100% | 2 |
10 | PIPERIDINEDIONES | authKW | 213672 | 1% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 1304 | 35% | 0% | 104 |
2 | Pharmacology & Pharmacy | 528 | 26% | 0% | 77 |
3 | Toxicology | 201 | 8% | 0% | 25 |
4 | Integrative & Complementary Medicine | 97 | 2% | 0% | 7 |
5 | Chemistry, Medicinal | 64 | 5% | 0% | 15 |
6 | Endocrinology & Metabolism | 55 | 6% | 0% | 19 |
7 | Genetics & Heredity | 23 | 5% | 0% | 15 |
8 | Biochemistry & Molecular Biology | 18 | 11% | 0% | 33 |
9 | Literary Theory & Criticism | 11 | 0% | 0% | 1 |
10 | Literary Reviews | 10 | 0% | 0% | 1 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EQUIPE ONCOL CELLULAIRE MOL | 213672 | 1% | 100% | 2 |
2 | HEMOSTASE ENDOTHELIUM ANGIOGENESE | 120187 | 1% | 38% | 3 |
3 | CHIM BIOL BIOMAT | 106836 | 0% | 100% | 1 |
4 | CIBLAGE FONCT TUMEURS SOLIDESSMBII | 106836 | 0% | 100% | 1 |
5 | CNRS URM 502 | 106836 | 0% | 100% | 1 |
6 | EQUIPE ONCOL | 106836 | 0% | 100% | 1 |
7 | INTE UNIV HEMATOL | 106836 | 0% | 100% | 1 |
8 | KUMABE HOSP | 106836 | 0% | 100% | 1 |
9 | NEUROCHIRURG KLIN FN | 106836 | 0% | 100% | 1 |
10 | NEW PROACHES BRAIN TUMOR THER Y CNS CONSORTIUM | 106836 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 55707 | 11% | 2% | 31 |
2 | DRUG AND CHEMICAL TOXICOLOGY | 2731 | 2% | 0% | 6 |
3 | ENVIRONMENTAL AND MOLECULAR MUTAGENESIS | 2262 | 2% | 0% | 7 |
4 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1972 | 4% | 0% | 13 |
5 | AMERICAN JOURNAL OF CHINESE MEDICINE | 1804 | 2% | 0% | 6 |
6 | ANTICANCER RESEARCH | 1217 | 5% | 0% | 15 |
7 | CLINICAL CANCER RESEARCH | 1165 | 4% | 0% | 13 |
8 | CANCER RESEARCH THERAPY & CONTROL | 820 | 0% | 1% | 1 |
9 | ONCOLOGY REPORTS | 646 | 3% | 0% | 8 |
10 | MASSACHUSETTS REVIEW | 579 | 0% | 1% | 1 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHENYLACETATE | 869453 | 8% | 35% | 23 | Search PHENYLACETATE | Search PHENYLACETATE |
2 | PHENYLBUTYRATE | 615548 | 7% | 26% | 22 | Search PHENYLBUTYRATE | Search PHENYLBUTYRATE |
3 | BLEOMYCIN AMPLIFICATION | 549442 | 2% | 86% | 6 | Search BLEOMYCIN+AMPLIFICATION | Search BLEOMYCIN+AMPLIFICATION |
4 | ANTINEOPLASTON AS2 1 | 534181 | 2% | 100% | 5 | Search ANTINEOPLASTON+AS2+1 | Search ANTINEOPLASTON+AS2+1 |
5 | FENTONS PATHWAY | 320509 | 1% | 100% | 3 | Search FENTONS+PATHWAY | Search FENTONS+PATHWAY |
6 | SODIUM PHENYLACETATE NAPA | 320509 | 1% | 100% | 3 | Search SODIUM+PHENYLACETATE+NAPA | Search SODIUM+PHENYLACETATE+NAPA |
7 | ANTINEOPLASTON A10 | 284894 | 1% | 67% | 4 | Search ANTINEOPLASTON+A10 | Search ANTINEOPLASTON+A10 |
8 | ANTINEOPLASTON | 213672 | 1% | 100% | 2 | Search ANTINEOPLASTON | Search ANTINEOPLASTON |
9 | PIPERIDINEDIONES | 213672 | 1% | 100% | 2 | Search PIPERIDINEDIONES | Search PIPERIDINEDIONES |
10 | SODIUM PHENYLACETATE | 155393 | 1% | 36% | 4 | Search SODIUM+PHENYLACETATE | Search SODIUM+PHENYLACETATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |